EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial

Metha Yaikwawong, Laddawan Jansarikit, Siwanon Jirawatnotai, Somlak Chuengsamarn

Nutrients · 2024

DOI: 10.3390/nu16152414 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Metha Yaikwawong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Hauptthemen laut MEDLINE: Curcumin, Diabetes Mellitus, Type 2, Obesity, Depression. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Reserach Fund, Thailand Research Fund, Thai Traditional Medical Knowledge Fund, Ministry of Public Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes and depression co-occur in a bidirectional manner. Curcumin supplements exhibit antidepressant effects that may mitigate depression by modulating neurotransmitters and reducing inflammatory and oxidative stress pathways. This study aimed to evaluate the efficacy of curcumin in improving depression severity in obese type 2 diabetes patients. The study employed a randomized, double-blind, placebo-controlled trial design with 227 participants. The primary end-point was depression severity assessed using the Patient Health Questionnaire-9. Biomarkers were measured at baseline and at 3-, 6-, 9-, and 12-month intervals. The biomarkers assessed were serotonin levels, pro-inflammatory cytokines (interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha), antioxidant activities (total antioxidant status, glutathione peroxidase, and superoxide dismutase), and malondialdehyde. After 12 months, the curcumin group exhibited significantly improved depression severity (p = 0.000001). The curcumin group had higher levels of serotonin (p < 0.0001) but lower levels of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha (p < 0.001 for all) than the placebo group. Total antioxidant status, glutathione peroxidase activity, and superoxide dismutase activity were elevated in the curcumin group, whereas malondialdehyde levels were greater in the placebo group (p < 0.001 for all). These findings suggest curcumin may have antidepressant effects on obese type 2 diabetes patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminDiabetes Mellitus, Type 2ObesityDepressionAntioxidantsBiomarkersHumansMaleDouble-Blind MethodFemaleMiddle AgedMalondialdehydeOxidative StressSerotoninAntidepressive AgentsAdultGlutathione PeroxidaseSuperoxide DismutaseCytokines

Stichwörter der Autor:innen

curcumindepressionobesityserotonintype 2 diabetes

Substanzen

CurcuminAntioxidantsBiomarkersMalondialdehydeSerotoninAntidepressive AgentsGlutathione PeroxidaseSuperoxide DismutaseCytokines

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Siriraj Center of Research Excellence for Precision Medicine and Systems Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
  • Division of Endocrinology and Metabolism, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Nakhon Nayok 26120, Thailand.

Förderung

  • Thailand Reserach Fund
  • Thailand Research Fund
  • Thai Traditional Medical Knowledge Fund, Ministry of Public Health

Zitieren

APA

Yaikwawong, M., Jansarikit, L., Jirawatnotai, S., & Chuengsamarn, S. (2024). Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu16152414

Vancouver

Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S. Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients. 2024. doi:10.3390/nu16152414

BibTeX
@article{Yaikwawong2024,
  author = {Yaikwawong, Metha and Jansarikit, Laddawan and Jirawatnotai, Siwanon and Chuengsamarn, Somlak},
  title = {Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16152414}
}
Kostenlos starten →